Drugs / etanidazole
etanidazole
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT00028782 | Oct 2001 → Sep 2007 | malignant mesothelioma, primary peritoneal carcinoma | National Cancer Institute (NCI) | Terminated | No outcome recorded |
| — | NCT00430079 | Jul 2001 → Sep 2007 | adult anaplastic ependymoma, adult brain ependymoma, adult glioblastoma, adult oligodendroglioma +9 | National Cancer Institute (NCI) | Terminated | No outcome recorded |
Evidence & citations 7 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | etanidazole | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00028782 ↗ |
| Known as | Etanidazol | ChEMBL registry synonym — accepted as the source's own label CHEMBL47405 ↗ |
| Known as | NSC-301467 | ChEMBL registry synonym — accepted as the source's own label CHEMBL47405 ↗ |
| Known as | Radinyl | ChEMBL registry synonym — accepted as the source's own label CHEMBL47405 ↗ |
| Known as | SR 2508 | ChEMBL registry synonym — accepted as the source's own label CHEMBL47405 ↗ |
| Modality | Small molecule | — CHEMBL47405 ↗ |
| Route | Intravenous | “Given IV” NCT00028782 ↗ |